Spinocerebellar Ataxia type 17 presenting with progressive myoclonic epilepsy

•SCA17 should be included in the differential diagnoses of PMEs.•SCA17 is characterized by cerebellar features, myoclonic epilepsy, cognitive decline, psychiatric features, and chorea.•Subtle clinical signs like chorea can provide additional diagnostic clues to SCA17(HDL4), a Huntington disease phen...

Full description

Saved in:
Bibliographic Details
Published in:eNeurologicalSci 2023-06, Vol.31, p.100463-100463, Article 100463
Main Authors: Boongird, Apisit, Termsarasab, Pichet, Pulkes, Teeratorn
Format: Article
Language:English
Subjects:
Letters to the Editor
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3913-d1ecb1c8534cea378a69de727c39c7cf53c86581658074b312bf74d76a3faa3
container_end_page 100463
container_issue
container_start_page 100463
container_title eNeurologicalSci
container_volume 31
creator Boongird, Apisit
Termsarasab, Pichet
Pulkes, Teeratorn
description •SCA17 should be included in the differential diagnoses of PMEs.•SCA17 is characterized by cerebellar features, myoclonic epilepsy, cognitive decline, psychiatric features, and chorea.•Subtle clinical signs like chorea can provide additional diagnostic clues to SCA17(HDL4), a Huntington disease phenocopy.
doi_str_mv 10.1016/j.ensci.2023.100463
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_875c425377504743b724c730bac1afce</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2405650223000217</els_id><doaj_id>oai_doaj_org_article_875c425377504743b724c730bac1afce</doaj_id><sourcerecordid>2811214824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3913-d1ecb1c8534cea378a69de727c39c7cf53c86581658074b312bf74d76a3faa3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EolXpL0BCOXLZrb8nPSBUVUArFXEod8uZTLZeZeNgZxf23-PdlKq9cLBsz7zzjD0vY-8FXwou7MV6SUPGsJRcqhLh2qpX7FRqbhbWcPn62fmEnee85pwLY6UV8i07USCMlACn7Pv9GIaIlKihvvepupr8n-CraT9SJaAaE2UapjCsqt9heij3uCqhHHZUbfYR-zgErGgMPY15_4696Xyf6fxxP2P3X7_8vL5Z3P34dnt9dbdAdSnUohWEjcDaKI3kFdTeXrYEEkoaATujsLamFmVx0I0SsulAt2C96rxXZ-x2prbRr92YwsanvYs-uGMgppXzaQrYk6vBoJZGARiuQasGpEZQvPEofIdUWJ9n1rhtNtRi-Wvy_Qvoy8wQHtwq7tzBBW5rXQgfHwkp_tpSntwmZDwMc6C4zU7WQkiha3mQqlmKKeacqHvqI_gR6NbuaKs72OpmW0vVh-dPfKr5Z2IRfJoFVEa-C5RcQdCA1IZEOJWphP82-AuphbTT</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2811214824</pqid></control><display><type>article</type><title>Spinocerebellar Ataxia type 17 presenting with progressive myoclonic epilepsy</title><source>ScienceDirect®</source><source>PMC (PubMed Central)</source><creator>Boongird, Apisit ; Termsarasab, Pichet ; Pulkes, Teeratorn</creator><creatorcontrib>Boongird, Apisit ; Termsarasab, Pichet ; Pulkes, Teeratorn</creatorcontrib><description>•SCA17 should be included in the differential diagnoses of PMEs.•SCA17 is characterized by cerebellar features, myoclonic epilepsy, cognitive decline, psychiatric features, and chorea.•Subtle clinical signs like chorea can provide additional diagnostic clues to SCA17(HDL4), a Huntington disease phenocopy.</description><identifier>ISSN: 2405-6502</identifier><identifier>EISSN: 2405-6502</identifier><identifier>DOI: 10.1016/j.ensci.2023.100463</identifier><identifier>PMID: 37152277</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Letters to the Editor</subject><ispartof>eNeurologicalSci, 2023-06, Vol.31, p.100463-100463, Article 100463</ispartof><rights>2023 The Authors</rights><rights>2023 The Authors.</rights><rights>2023 The Authors 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3913-d1ecb1c8534cea378a69de727c39c7cf53c86581658074b312bf74d76a3faa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160684/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2405650223000217$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3547,27923,27924,45779,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37152277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boongird, Apisit</creatorcontrib><creatorcontrib>Termsarasab, Pichet</creatorcontrib><creatorcontrib>Pulkes, Teeratorn</creatorcontrib><title>Spinocerebellar Ataxia type 17 presenting with progressive myoclonic epilepsy</title><title>eNeurologicalSci</title><addtitle>eNeurologicalSci</addtitle><description>•SCA17 should be included in the differential diagnoses of PMEs.•SCA17 is characterized by cerebellar features, myoclonic epilepsy, cognitive decline, psychiatric features, and chorea.•Subtle clinical signs like chorea can provide additional diagnostic clues to SCA17(HDL4), a Huntington disease phenocopy.</description><subject>Letters to the Editor</subject><issn>2405-6502</issn><issn>2405-6502</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kU1v1DAQhi0EolXpL0BCOXLZrb8nPSBUVUArFXEod8uZTLZeZeNgZxf23-PdlKq9cLBsz7zzjD0vY-8FXwou7MV6SUPGsJRcqhLh2qpX7FRqbhbWcPn62fmEnee85pwLY6UV8i07USCMlACn7Pv9GIaIlKihvvepupr8n-CraT9SJaAaE2UapjCsqt9heij3uCqhHHZUbfYR-zgErGgMPY15_4696Xyf6fxxP2P3X7_8vL5Z3P34dnt9dbdAdSnUohWEjcDaKI3kFdTeXrYEEkoaATujsLamFmVx0I0SsulAt2C96rxXZ-x2prbRr92YwsanvYs-uGMgppXzaQrYk6vBoJZGARiuQasGpEZQvPEofIdUWJ9n1rhtNtRi-Wvy_Qvoy8wQHtwq7tzBBW5rXQgfHwkp_tpSntwmZDwMc6C4zU7WQkiha3mQqlmKKeacqHvqI_gR6NbuaKs72OpmW0vVh-dPfKr5Z2IRfJoFVEa-C5RcQdCA1IZEOJWphP82-AuphbTT</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Boongird, Apisit</creator><creator>Termsarasab, Pichet</creator><creator>Pulkes, Teeratorn</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230601</creationdate><title>Spinocerebellar Ataxia type 17 presenting with progressive myoclonic epilepsy</title><author>Boongird, Apisit ; Termsarasab, Pichet ; Pulkes, Teeratorn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3913-d1ecb1c8534cea378a69de727c39c7cf53c86581658074b312bf74d76a3faa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Letters to the Editor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boongird, Apisit</creatorcontrib><creatorcontrib>Termsarasab, Pichet</creatorcontrib><creatorcontrib>Pulkes, Teeratorn</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>eNeurologicalSci</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boongird, Apisit</au><au>Termsarasab, Pichet</au><au>Pulkes, Teeratorn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spinocerebellar Ataxia type 17 presenting with progressive myoclonic epilepsy</atitle><jtitle>eNeurologicalSci</jtitle><addtitle>eNeurologicalSci</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>31</volume><spage>100463</spage><epage>100463</epage><pages>100463-100463</pages><artnum>100463</artnum><issn>2405-6502</issn><eissn>2405-6502</eissn><abstract>•SCA17 should be included in the differential diagnoses of PMEs.•SCA17 is characterized by cerebellar features, myoclonic epilepsy, cognitive decline, psychiatric features, and chorea.•Subtle clinical signs like chorea can provide additional diagnostic clues to SCA17(HDL4), a Huntington disease phenocopy.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37152277</pmid><doi>10.1016/j.ensci.2023.100463</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2405-6502
ispartof eNeurologicalSci, 2023-06, Vol.31, p.100463-100463, Article 100463
issn 2405-6502
2405-6502
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_875c425377504743b724c730bac1afce
source ScienceDirect®; PMC (PubMed Central)
subjects Letters to the Editor
title Spinocerebellar Ataxia type 17 presenting with progressive myoclonic epilepsy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A14%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spinocerebellar%20Ataxia%20type%2017%20presenting%20with%20progressive%20myoclonic%20epilepsy&rft.jtitle=eNeurologicalSci&rft.au=Boongird,%20Apisit&rft.date=2023-06-01&rft.volume=31&rft.spage=100463&rft.epage=100463&rft.pages=100463-100463&rft.artnum=100463&rft.issn=2405-6502&rft.eissn=2405-6502&rft_id=info:doi/10.1016/j.ensci.2023.100463&rft_dat=%3Cproquest_doaj_%3E2811214824%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3913-d1ecb1c8534cea378a69de727c39c7cf53c86581658074b312bf74d76a3faa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2811214824&rft_id=info:pmid/37152277&rfr_iscdi=true